Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Angelman syndrome (AS) is a severe neurological disorder characterized by mental retardation, motor dysfunction and epilepsy. We show that the molecular and cellular deficits of an AS mouse model can be rescued by introducing an additional mutation at the inhibitory phosphorylation site of alphaCaMKII. Moreover, these double mutants no longer show the behavioral deficits seen in AS mice, suggesting that these deficits are the direct result of increased inhibitory phosphorylation of alphaCaMKII.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Several mouse models of ASD, including those of Rett syndrome96,97, Angelman syndrome98, tuberous sclerosis complex71, and Fragile X23 syndrome, and mouse models of rare mutations in SHANK proteins49, have provided convincing evidence that ASD phenotypes can be improved by genetic or pharmacological interventions”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,298
De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome
Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R.-J., Jiang, Y.-H., Benton, C. S., Rommens, J. M., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0197-74 · Cited by 856
Self-citationJiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Self-citationAlbrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., & Beaudet, A. L. (1997) · Nature Genetics · doi:10.1038/ng0997-75 · Cited by 583
Knoll, J. H. M., Nicholls, R. D., Magenis, R. E., Graham, J. M., Lalande, M., Latt, S. A., Opitz, J. M., & Reynolds, J. F. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320320235 · Cited by 576
Inhibitory Autophosphorylation of CaMKII Controls PSD Association, Plasticity, and Learning
Elgersma, Y., Fedorov, N. B., Ikonen, S., Choi, E. S., Elgersma, M., Carvalho, O. M., Giese, K. P., & Silva, A. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)01007-3 · Cited by 290
Self-citationWeeber, E. J., Jiang, Y.-H., Elgersma, Y., Varga, A. W., Carrasquillo, Y., Brown, S. E., Christian, J. M., Mirnikjoo, B., Silva, A., Beaudet, A. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02634.2003 · Cited by 264
Self-citationClayton‐Smith, J. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320460105 · Cited by 247
αCaMKII Is Essential for Cerebellar LTD and Motor Learning
Hansel, C., de Jeu, M., Belmeguenai, A., Houtman, S. H., Buitendijk, G. H. S., Andreev, D., De Zeeuw, C. I., & Elgersma, Y. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.013 · Cited by 230
Self-citationElgersma, Y., Sweatt, J. D., & Giese, K. P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3622-04.2004 · Cited by 148
Self-citation
Cited by
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
“Another important observation is that boosting the activity of α CaMKII (calcium-calmodulin-dependent protein kinase II) by mutating an inhibitory phosphorylation site can rescue LTP and learning deficits in the Ube3a mutant mice (van Woerden et al. 2007).”
BackgroundActivity-dependent neuronal signalling and autism spectrum disorder
Ebert, D. H., & Greenberg, M. E. (2013) · Nature · doi:10.1038/nature11860 · Cited by 666
Dindot, S. V., Antalffy, B. A., Bhattacharjee, M. B., & Beaudet, A. L. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm288 · Cited by 418
Genomic imprinting effects on brain development and function
Wilkinson, L. S., Davies, W., & Isles, A. R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2235 · Cited by 375
CaMKII: Claiming Center Stage in Postsynaptic Function and Organization
Hell, J. W. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.024 · Cited by 358
Ube3a is required for experience-dependent maturation of the neocortex
Yashiro, K., Riday, T. T., Condon, K. H., Roberts, A. C., Bernardo, D. R., Prakash, R., Weinberg, R. J., Ehlers, M. D., & Philpot, B. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2327 · Cited by 328
Synaptopathology Involved in Autism Spectrum Disorder
Guang, S., Pang, N., Deng, X., Yang, L., He, F., Wu, L., Chen, C., Yin, F., & Peng, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00470 · Cited by 286
Deconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease
Bingol, B., & Sheng, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.11.006 · Cited by 275
Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity
Gilbert, J., & Man, H.-Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00359 · Cited by 280
Liu, Q., Trotter, J., Zhang, J., Peters, M. M., Cheng, H., Bao, J., Han, X., Weeber, E. J., & Bu, G. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4067-10.2010 · Cited by 268
Self-citationSmith, S. E. P., Zhou, Y.-D., Zhang, G., Jin, Z., Stoppel, D. C., & Anderson, M. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002627 · Cited by 267
Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes
Mabb, A. M., Judson, M. C., Zylka, M. J., & Philpot, B. D. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.04.001 · Cited by 263
Ubiquitination in postsynaptic function and plasticity
Mabb, A. M., & Ehlers, M. D. (2010) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100109-104129 · Cited by 255
“One of the strongest genetic links to autism spectrum disorders (ASD) (∼1–5% of cases) are duplications of the 15q11-q13 chromosomal region (Vorstman et al. 2006).”
Intellectual disability and autism spectrum disorders: Causal genes and molecular mechanisms
Srivastava, A. K., & Schwartz, C. E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.015 · Cited by 249
Angelman syndrome: review of clinical and molecular aspects
Bird, L. (2014) · The Application of Clinical Genetics · doi:10.2147/tacg.s57386 · Cited by 238
Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model
Silva-Santos, S., van Woerden, G. M., Bruinsma, C. F., Mientjes, E., Jolfaei, M. A., Distel, B., Kushner, S. A., & Elgersma, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80554 · Cited by 238
Self-citationAn epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
The roles of protein kinases in learning and memory
Giese, K. P., & Mizuno, K. (2013) · Learning & Memory · doi:10.1101/lm.028449.112 · Cited by 233
Advances in behavioral genetics: mouse models of autism
Moy, S. S., & Nadler, J. J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002082 · Cited by 200
Reversing Neurodevelopmental Disorders in Adults
Ehninger, D., Li, W., Fox, K., Stryker, M. P., & Silva, A. J. (2008) · Neuron · doi:10.1016/j.neuron.2008.12.007 · Cited by 196
“…spatial learning deficits (Morris water maze), context fear conditioning deficits, increased body weight, deficient long-term potentiation van Woerden et al., 2007 eries of periments with ferent temporal tivation of ecp2 was rformed; tivation of ecp2 after tablishment of urological mptoms…”
BackgroundDe Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
Küry, S., van Woerden, G. M., Besnard, T., Proietti Onori, M., Latypova, X., Towne, M. C., Cho, M. T., Prescott, T. E., Ploeg, M. A., Sanders, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.10.003 · Cited by 185
Dendritic spine dysgenesis in autism related disorders
Phillips, M., & Pozzo-Miller, L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.011 · Cited by 176
Margolis, S. S., Sell, G. L., Zbinden, M. A., & Bird, L. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0361-y · Cited by 165
Jiang, Y.-H., Pan, Y., Zhu, L., Landa, L., Yoo, J., Spencer, C., Lorenzo, I., Brilliant, M., Noebels, J., & Beaudet, A. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012278 · Cited by 172
Self-citationImpairment of TrkB-PSD-95 Signaling in Angelman Syndrome
Cao, C., Rioult-Pedotti, M. S., Migani, P., Yu, C. J., Tiwari, R., Parang, K., Spaller, M. R., Goebel, D. J., & Marshall, J. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001478 · Cited by 171
A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
George, A. J., Hoffiz, Y. C., Charles, A. J., Zhu, Y., & Mabb, A. M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00029 · Cited by 172
Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders
Stornetta, R. L., & Zhu, J. J. (2011) · The Neuroscientist · doi:10.1177/1073858410365562 · Cited by 158
A Neurodevelopmental Survey of Angelman Syndrome With Genotype-Phenotype Correlations
Gentile, J. K., Tan, W.-H., Horowitz, L. T., Bacino, C. A., Skinner, S. A., Barbieri-Welge, R., Bauer-Carlin, A., Beaudet, A. L., Bichell, T. J., Lee, H.-S., et al. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181ee408e · Cited by 158
Behavioral profiles of mouse models for autism spectrum disorders
Ey, E., Leblond, C. S., & Bourgeron, T. (2011) · Autism Research · doi:10.1002/aur.175 · Cited by 161
Judson, M. C., Wallace, M. L., Sidorov, M. S., Burette, A. C., Gu, B., van Woerden, G. M., King, I. F., Han, J. E., Zylka, M. J., Elgersma, Y., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.040 · Cited by 159
Self-citationEmerging role of CaMKII in neuropsychiatric disease
Robison, A. J. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.001 · Cited by 159
Molecular and Clinical Aspects of Angelman Syndrome
Dagli, A. I., Buiting, K., & Williams, C. A. (2011) · Molecular Syndromology · doi:10.1159/000328837 · Cited by 166
Behavioral deficits in an Angelman syndrome model: Effects of genetic background and age
Huang, H.-S., Burns, A. J., Nonneman, R. J., Baker, L. K., Riddick, N. V., Nikolova, V. D., Riday, T. T., Yashiro, K., Philpot, B. D., & Moy, S. S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.052 · Cited by 142
Experimental models of Rett syndrome based on Mecp2 dysfunction
Calfa, G., Percy, A. K., & Pozzo-Miller, L. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010261 · Cited by 132
UBE3A Regulates Synaptic Plasticity and Learning and Memory by Controlling SK2 Channel Endocytosis
Sun, J., Zhu, G., Liu, Y., Standley, S., Ji, A., Tunuguntla, R., Wang, Y., Claus, C., Luo, Y., Baudry, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.023 · Cited by 131
Pelc, K., Boyd, S. G., Cheron, G. A., & Dan, B. (2007) · Seizure · doi:10.1016/j.seizure.2007.08.004 · Cited by 130
Kaphzan, H., Buffington, S. A., Jung, J. I., Rasband, M. N., & Klann, E. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4162-11.2011 · Cited by 130
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
“…disorders that bear ASD features have demonstrated remarkable reductions, and in some cases elimination of behavioral deficits following either genetic and/or pharmacological manipulations (Ehninger et al, 2008a; Guy et al, 2007; Tropea et al, 2009; van Woerden et al, 2007; Zhou et al, 2009).”
BackgroundStephenson, J. R., Wang, X., Perfitt, T. L., Parrish, W. P., Shonesy, B. C., Marks, C. R., Mortlock, D. P., Nakagawa, T., Sutcliffe, J. S., & Colbran, R. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2068-16.2017 · Cited by 127
Pi, H. J., Otmakhov, N., Lemelin, D., De Koninck, P., & Lisman, J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0133-10.2010 · Cited by 125
“As suggested by the involvement of T305/T306 in metaplasticity (Zhang et al., 2005) and Angelman syndrome (Weeber et al., 2003; van Woerden et al., 2007), we assume that the cross-over point in the Bienenstock–Cooper– Munro (BCM) curve (Bienenstock et al., 1982) that relates LTP and LTD to firing…”
BackgroundDaily, J. L., Nash, K., Jinwal, U., Golde, T., Rogers, J., Peters, M. M., Burdine, R. D., Dickey, C., Banko, J. L., & Weeber, E. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027221 · Cited by 123
Self-citationAnalysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors
Heck, D. H., Zhao, Y., Roy, S., LeDoux, M. S., & Reiter, L. T. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn117 · Cited by 121
Borgesius, N. Z., van Woerden, G. M., Buitendijk, G. H. S., Keijzer, N., Jaarsma, D., Hoogenraad, C. C., & Elgersma, Y. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5105-10.2011 · Cited by 124
Self-citationHornsby, A. K. E., Redhead, Y. T., Rees, D. J., Ratcliff, M. S. G., Reichenbach, A., Wells, T., Francis, L., Amstalden, K., Andrews, Z. B., & Davies, J. S. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.023 · Cited by 121
Angelman Syndrome, a Genomic Imprinting Disorder of the Brain
Chamberlain, S. J., & Lalande, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1728-10.2010 · Cited by 118
Sidorov, M. S., Deck, G. M., Dolatshahi, M., Thibert, R. L., Bird, L. M., Chu, C. J., & Philpot, B. D. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9195-8 · Cited by 113
Age-related motor neuron degeneration in DNA repair-deficient Ercc1 mice
de Waard, M. C., van der Pluijm, I., Zuiderveen Borgesius, N., Comley, L. H., Haasdijk, E. D., Rijksen, Y., Ridwan, Y., Zondag, G., Hoeijmakers, J. H. J., Elgersma, Y., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0715-9 · Cited by 110
Self-citationBehavior and neuropsychiatric manifestations in Angelman syndrome
Dan, B. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2749 · Cited by 108
Sonzogni, M., Wallaard, I., Santos, S. S., Kingma, J., du Mee, D. J. M., van Woerden, G. M., & Elgersma, Y. (2018) · Molecular Autism · doi:10.1186/s13229-018-0231-7 · Cited by 116
Self-citationGustin, R. M., Bichell, T. J., Bubser, M., Daily, J., Filonova, I., Mrelashvili, D., Deutch, A. Y., Colbran, R. J., Weeber, E. J., & Haas, K. F. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.012 · Cited by 107
Self-citationThe behavioral phenotype of the Angelman syndrome
Williams, C. A. (2010) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30278 · Cited by 116
Baudry, M., Kramar, E., Xu, X., Zadran, H., Moreno, S., Lynch, G., Gall, C., & Bi, X. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.002 · Cited by 105
Ciarlone, S. L., Grieco, J. C., D’Agostino, D. P., & Weeber, E. J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.002 · Cited by 116
Self-citationDisrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells
Fink, J. J., Robinson, T. M., Germain, N. D., Sirois, C. L., Bolduc, K. A., Ward, A. J., Rigo, F., Chamberlain, S. J., & Levine, E. S. (2017) · Nature Communications · doi:10.1038/ncomms15038 · Cited by 112
Perez, J. D., Rubinstein, N. D., & Dulac, C. G. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113708 · Cited by 112
Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11–q13
Chamberlain, S. J., & Lalande, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.011 · Cited by 102
MeCP2 and Rett syndrome: reversibility and potential avenues for therapy
Gadalla, K. K. E., Bailey, M. E. S., & Cobb, S. R. (2011) · Biochemical Journal · doi:10.1042/bj20110648 · Cited by 98
Are there distinctive sleep problems in Angelman syndrome?
Pelc, K., Cheron, G. A., Boyd, S. G., & Dan, B. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2007.07.001 · Cited by 100
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 96
Heus, K. B., Mous, S. E., Radstaake, M., van Iperen‐Kolk, B. M., Navis, C., Rietman, A. B., ten Hoopen, L. W., Brooks, A. S., Elgersma, Y., Moll, H. A., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61382 · Cited by 95
Self-citationFujii, H., Inoue, M., Okuno, H., Sano, Y., Takemoto-Kimura, S., Kitamura, K., Kano, M., & Bito, H. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.033 · Cited by 96
Khatri, N., & Man, H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00109 · Cited by 107
Kaphzan, H., Hernandez, P., Jung, J. I., Cowansage, K. K., Deinhardt, K., Chao, M. V., Abel, T., & Klann, E. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.021 · Cited by 92
Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact
Ehlen, J. C., Jones, K. A., Pinckney, L., Gray, C. L., Burette, S., Weinberg, R. J., Evans, J. A., Brager, A. J., Zylka, M. J., Paul, K. N., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2194-15.2015 · Cited by 98
Epilepsy in Angelman syndrome: A scoping review
Samanta, D. (2020) · Brain and Development · doi:10.1016/j.braindev.2020.08.014 · Cited by 94
HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
Omrani, A., van der Vaart, T., Mientjes, E., van Woerden, G. M., Hojjati, M. R., Li, K. W., Gutmann, D. H., Levelt, C. N., Smit, A. B., Silva, A. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.48 · Cited by 91
Self-citationUBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27
Mishra, A., Godavarthi, S. K., & Jana, N. R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.010 · Cited by 90
Genetic and epigenetic defects in mental retardation
Kramer, J. M., & van Bokhoven, H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.009 · Cited by 104
Cerebellar network plasticity: From genes to fast oscillation
Cheron, G. A., Servais, L., & Dan, B. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.074 · Cited by 90
Su, H., Fan, W., Coskun, P. E., Vesa, J., Gold, J.-A., Jiang, Y.-H., Potluri, P., Procaccio, V., Acab, A., Weiss, J. H., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.079 · Cited by 80
Self-citationAngelman Syndrome: From Mouse Models to Therapy
Rotaru, D. C., Mientjes, E., & Elgersma, Y. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.017 · Cited by 85
Self-citationMandel‐Brehm, C., Salogiannis, J., Dhamne, S. C., Rotenberg, A., & Greenberg, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504809112 · Cited by 83
Kaphzan, H., Buffington, S. A., Ramaraj, A. B., Lingrel, J. B., Rasband, M. N., Santini, E., & Klann, E. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.005 · Cited by 84
Angelman syndrome: Current understanding and research prospects
Dan, B. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02311.x · Cited by 83
Lu, Y., Wang, F., Li, Y., Ferris, J., Lee, J.-A., & Gao, F.-B. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn373 · Cited by 76
Rotaru, D. C., van Woerden, G. M., Wallaard, I., & Elgersma, Y. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0083-18.2018 · Cited by 74
Self-citationSun, J., Liu, Y., Moreno, S., Baudry, M., & Bi, X. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-14.2015 · Cited by 75
Santini, E., Turner, K. L., Ramaraj, A. B., Murphy, M. P., Klann, E., & Kaphzan, H. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2246-15.2015 · Cited by 75
Baucum, A. J., Shonesy, B. C., Rose, K. L., & Colbran, R. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500337u · Cited by 73
From UBE3A to Angelman syndrome: a substrate perspective
Sell, G. L., & Margolis, S. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00322 · Cited by 70
The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer
Ronchi, V. P., Klein, J. M., Edwards, D. J., & Haas, A. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517805 · Cited by 79
On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity
Ledonne, A., & Mercuri, N. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010275 · Cited by 78
Shioda, N., Beppu, H., Fukuda, T., Li, E., Kitajima, I., & Fukunaga, K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4816-10.2011 · Cited by 68
Sun, J., Liu, Y., Tran, J., O’Neal, P., Baudry, M., & Bi, X. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2269-z · Cited by 78
Reversibility of functional deficits in experimental models of Rett syndrome
Cobb, S., Guy, J., & Bird, A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380498 · Cited by 67
Wei, G., Chen, Y., Chen, D., Lai, X., Liu, D., Deng, R., Zhou, J., Zhang, S., Li, Y.-W., Lii, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120865 · Cited by 67
Dendritic spine actin cytoskeleton in autism spectrum disorder
Joensuu, M., Lanoue, V., & Hotulainen, P. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.023 · Cited by 65
Roles of ubiquitination at the synapse
Haas, K. F., & Broadie, K. S. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.12.010 · Cited by 73
Rett syndrome: from bed to bench.
Weng, S.-M., Bailey, M., & Cobb, S. (2011) · Pediatrics and Neonatology · doi:10.1016/j.pedneo.2011.08.002 · Cited by 59
Kuijpers, M., van Dis, V., Haasdijk, E. D., Harterink, M., Vocking, K., Post, J. A., Scheper, W., Hoogenraad, C. C., & Jaarsma, D. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-24 · Cited by 63
An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome
Grieco, J. C., Ciarlone, S. L., Gieron-Korthals, M. A., Schoenberg, M. R., Smith, A., Philpot, R. M., Heussler, H., Banko, J. L., & Weeber, E. J. (2014) · BMC Neurology · doi:10.1186/s12883-014-0232-x · Cited by 65
Self-citationBerg, E. L., Pride, M. C., Petkova, S. P., Lee, R. D., Copping, N. A., Shen, Y., Adhikari, A., Fenton, T. A., Pedersen, L. R., Noakes, L. S., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0720-2 · Cited by 65
Self-citationGene therapy and neurodevelopmental disorders
Gray, S. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.024 · Cited by 64
Hethorn, W. R., Ciarlone, S. L., Filonova, I., Rogers, J. T., Aguirre, D., Ramirez, R. A., Grieco, J. C., Peters, M. M., Gulick, D., Anderson, A. E., et al. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12893 · Cited by 56
Self-citationPastuzyn, E. D., & Shepherd, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00234 · Cited by 56
Epigenetic regulation in memory and cognitive disorders
Rudenko, A., & Tsai, L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.034 · Cited by 61
Wang, D., Tan, Q.-R., & Zhang, Z.-J. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0031-7 · Cited by 57
Steinkellner, T., Yang, J.-W., Montgomery, T. R., Chen, W.-Q., Winkler, M.-T., Sucic, S., Lubec, G., Freissmuth, M., Elgersma, Y., Sitte, H. H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367219 · Cited by 56
Self-citationUBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Elgersma, Y., & Sonzogni, M. (2021) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14831 · Cited by 62
Self-citationDelayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
Sonzogni, M., Hakonen, J., Kleijn, M. B., Silva-Santos, S., Judson, M. C., Philpot, B. D., van Woerden, G. M., & Elgersma, Y. (2019) · Molecular Autism · doi:10.1186/s13229-019-0277-1 · Cited by 60
Self-citation
Metadata
- Authors
- van Woerden, G. M., Harris, K. D., Hojjati, M. R., Gustin, R. M., Qiu, S., de Avila Freire, R., Jiang, Y.-H., Elgersma, Y., & Weeber, E. J.
- Affiliations
- Vanderbilt University (US)
- Erasmus MC (NL)
- Baylor College of Medicine (US)
- Corresponding author
- Elgersma, Ype
- Venue
- Nature Neuroscience
- Published
- 2007-01-28
- Volume
- 10
- Issue
- 3
- Pages
- 280-282
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2149631083
- Cited by
- 281
- References
- 15
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 9 · 2023: 8 · 2022: 9 · 2021: 14 · 2020: 19 · 2019: 14 · 2018: 10 · 2017: 20 · 2016: 11 · 2015: 27 · 2014: 17 · 2013: 19 · 2012: 18
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Angelman syndrome, CaMKIIα, inhibitory phosphorylation, mouse model, neurological deficit, intellectual disability, epilepsy, motor impairment
- MeSH terms
- Animals, Behavior, Animal, Mental Disorders, Conditioning, Classical, Disease Models, Animal, Female, Hippocampus, Male, Mice, Inbred C57BL, Mice, Neurologic Mutants, Motor Activity, Phosphorylation, Phosphotransferases, Reaction Time, Time Factors, Angelman Syndrome, Maze Learning, Excitatory Postsynaptic Potentials, Ubiquitin-Protein Ligases, Freezing Reaction, Cataleptic, Mice, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.